Next report date
Report period
Q1 2024
EPS estimate
−0.42USD
Revenue estimate
11.17 MUSD
−328.07 MUSD
44.58 MUSD
146.66 M
Om Recursion Pharmaceuticals, Inc.
Sektor
Bransch
VD
Chistopher C. Gibson
Webbplats
Huvudkvarter
Salt Lake City
Grundat
2013
FIGI
BBG00PQ4XJ45
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
